Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter...

by Singer, Barry, Bandari, Daniel, Cascione, Mark, LaGanke, Christopher, Huddlestone, John, Bennett, Randy, Dangond, Fernando
Published 2012

IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS

by Scagnolari, Carolina, Selvaggi, Carla, Di Biase, Emilia, Fraulo, Maurizio, Dangond, Fernando, Antonelli, Guido
Published 2014

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study

by Rivera, Victor M, Jeffery, Douglas R, Weinstock-Guttman, Bianca, Bock, Daena, Dangond, Fernando
Published 2013

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting...

by Zivadinov, Robert, Dwyer, Michael G., Markovic-Plese, Silva, Kennedy, Cheryl, Bergsland, Niels, Ramasamy, Deepa P., Durfee, Jacqueline, Hojnacki, David, Hayward, Brooke, Dangond, Fernando, Weinstock-Guttman, Bianca
Published 2014

Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS

by Tao, Yazhong, Zhang, Xin, Zivadinov, Robert, Dwyer, Michael G., Kennedy, Cheryl, Bergsland, Niels, Ramasamy, Deepa, Durfee, Jacqueline, Hojnacki, David, Hayward, Brooke, Dangond, Fernando, Weinstock-Guttman, Bianca, Markovic-Plese, Silva
Published 2015

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm...

by Dwyer, Michael G., Zivadinov, Robert, Tao, Yazhong, Zhang, Xin, Kennedy, Cheryl, Bergsland, Niels, Ramasamy, Deepa P., Durfee, Jackie, Hojnacki, David, Weinstock-Guttman, Bianca, Hayward, Brooke, Dangond, Fernando, Markovic-Plese, Silva
Published 2015